Trademark Attorney / Law Firm

Blaine Knight – Trademark Portfolio

Blaine Knight specializes in Class 41 (Education & Entertainment) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 2 other Nice Classification classes. Filing activity spans from 2008 to 2022. Currently, 1 trademark is registered.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

TRME
TRME
Registered 2022
LDSTIMES
LDSTIMES
Abandoned 2008

Practice Areas by Trademark Class

Blaine Knight's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademark applications has Blaine Knight filed?

Blaine Knight has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned.

What trademark classes does Blaine Knight specialize in?

Blaine Knight has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

How long has Blaine Knight been filing trademarks?

Blaine Knight's trademark filing history with the USPTO spans from 2008 to 2022, covering 14 years of trademark practice. During this period, Blaine Knight has handled 2 trademark applications.

What is Blaine Knight's trademark registration success rate?

Blaine Knight has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.